AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,129 | +36.1% | 3,348 | 0.0% | 0.00% | – |
| Q2 2023 | $10,379 | +126.3% | 3,348 | +1.5% | 0.00% | – |
| Q1 2023 | $4,587 | -48.7% | 3,300 | -26.5% | 0.00% | – |
| Q4 2022 | $8,933 | -10.7% | 4,489 | -13.0% | 0.00% | – |
| Q3 2022 | $10,000 | -16.7% | 5,158 | +31.5% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 3,921 | +19.3% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 3,288 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -11.1% | 3,288 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $18,000 | +5.9% | 3,288 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | +750.0% | 3,288 | +1041.7% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 288 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |